Role of apolipoprotein E in the molecular pathomechanism of Alzheimer disease

被引:0
|
作者
Michikawa, Makoto [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan
来源
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Apolipoprotein E (Apo-E) is a major cholesterol carrier regulating lipid transport and injury repair in the brain. It is known that individuals carrying the epsilon 4 allele are at increased risk of Alzheimer disease (AD) compared with those carrying the more common epsilon 3 allele, whereas the epsilon 2 allele decreases risk. ApoE-HDL binds to several cell-surface receptors to deliver lipids, and also to amyloid-beta (A beta) proteins. A beta is thought to initiate toxic events that lead to synaptic dysfunction and neurodegeneration in AD. It has been shown that Apo-E isoforms differentially regulate A beta aggregation and clearance in the brain, and have distinct functions in regulating brain lipid transport, and mitochondrial function. In this review, we summarize current knowledge about Apo-E in the CNS, with a particular emphasis on its functions to generate HDL and clear/degradate of HDL-bound A beta with different ApoE isoforms.
引用
收藏
页码:5 / 9
页数:5
相关论文
共 50 条
  • [1] Role of apolipoprotein E in the pathogenesis of Alzheimer's disease and molecular mechanisms
    Song, Zhenhai
    Xu, Shuo
    Song, Bin
    Zhang, Qinghua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4615 - 4621
  • [2] The Role of Apolipoprotein E in Alzheimer's Disease
    Kim, Jungsu
    Basak, Jacob M.
    Holtzman, David M.
    NEURON, 2009, 63 (03) : 287 - 303
  • [3] Role of apolipoprotein E in Alzheimer's disease
    Zannis, VI
    Zanni, EE
    Makrides, SC
    Kardassis, D
    Aleshkov, S
    VASCULAR ENDOTHELIUM: PHARMACOLOGIC AND GENETIC MANIPULATIONS, 1998, 294 : 179 - 209
  • [4] The Role of Apolipoprotein E Isoforms in Alzheimer's Disease
    Roda, Alejandro R.
    Montoliu-Gaya, Laia
    Villegas, Sandra
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (02) : 459 - 471
  • [5] Apolipoprotein E and Alzheimer disease
    Lahoz, C
    Ordovas, JM
    REVISTA CLINICA ESPANOLA, 1997, 197 (02): : 73 - 74
  • [6] Apolipoprotein E and Alzheimer disease
    Huang, YD
    NEUROLOGY, 2006, 66 : S79 - S85
  • [7] Apolipoprotein E and Alzheimer disease
    Growdon, JH
    ARCHIVES OF NEUROLOGY, 1998, 55 (08) : 1053 - 1054
  • [8] Apolipoprotein E and Alzheimer disease
    Roses, AD
    Saunders, AM
    Corder, EH
    Risch, NJ
    Haines, JL
    PericakVance, MA
    Han, SH
    Einstein, G
    Hulette, C
    Schmechel, DE
    Goedert, M
    Jakes, R
    Dong, LM
    Weisgraber, KH
    Holsti, M
    Huang, D
    Strittmatter, WJ
    PRECLINICAL AND CLINICAL STRATEGIES FOR THE TREATMENT OF NEURODEGENERATIVE, CEREBROVASCULAR AND MENTAL DISORDERS, 1996, 11 : 187 - 197
  • [9] Apolipoprotein E region molecular signatures of Alzheimer's disease
    Kulminski, Alexander M.
    Huang, Jian
    Wang, Jiayi
    He, Liang
    Loika, Yury
    Culminskaya, Irina
    AGING CELL, 2018, 17 (04)
  • [10] Apolipoprotein E and Alzheimer's disease - A role in amyloid catabolism
    Poirier, J
    ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 81 - 90